000 01434 a2200397 4500
005 20250517084049.0
264 0 _c20160721
008 201607s 0 0 eng d
022 _a0392-856X
040 _aNLM
_beng
_cNLM
100 1 _aHodge, Jennifer A
245 0 0 _aThe mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.
_h[electronic resource]
260 _bClinical and experimental rheumatology
_c
300 _a318-28 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aCytokines
_xphysiology
650 0 4 _aHumans
650 0 4 _aJanus Kinases
_xantagonists & inhibitors
650 0 4 _aLymphocyte Subsets
_xdrug effects
650 0 4 _aNeutrophils
_xdrug effects
650 0 4 _aPiperidines
_xpharmacology
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aPyrroles
_xpharmacology
650 0 4 _aSignal Transduction
_xphysiology
700 1 _aKawabata, Thomas T
700 1 _aKrishnaswami, Sriram
700 1 _aClark, James D
700 1 _aTelliez, Jean-Baptiste
700 1 _aDowty, Martin E
700 1 _aMenon, Sujatha
700 1 _aLamba, Manisha
700 1 _aZwillich, Samuel
773 0 _tClinical and experimental rheumatology
_gvol. 34
_gno. 2
_gp. 318-28
999 _c25817839
_d25817839